This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Date, H. Articles by Ohe, T. Search for Related Content PubMed Articles by Date, H. Articles by Ohe, T.

Living-Donor Lobar Lung Transplantation for Pulmonary Arterial Hypertension After Failure of Epoprostenol Therapy

Hiroshi Date, MD^_*,_*, Kengo Fukushima Kusano, MD, Hiromi Matsubara, MD, Aiko Ogawa, MD, Hideki Fujio, MD, Katsumasa Miyaji, MD, Megumi Okazaki, RN^_*, Masaomi Yamane, MD^_*, Shinichi Toyooka, MD^_*, Motoi Aoe, MD^_*, Yoshifumi Sano, MD^_*, Motohiko Hanazaki, MD, Keiji Goto, MD, Shingo Kasahara, MD, Shunji Sano, MD and Tohru Ohe, MD

^_* Department of Cancer and Thoracic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
Department of Anesthesiology and Resuscitology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
Department of Cardiovascular Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.

View larger version (12K): [in this window] [in a new window] [Download PPT slide]   Figure 1 Kaplan-Meier Survival Curves in PAH Patients Survival was assessed from the date of operation in patients receiving transplantation and from the date of acceptance as lung transplant candidates in patients treated medically. The survival was significantly better in patients receiving living-donor lobar lung transplantation (LDLLT) than in patients medically treated. p = 0.028, log-rank test. CLT = cadaveric lung transplantation; PAH = pulmonary arterial hypertension.